Publication related to RSI or an RSI staff member

Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada.

BACKGROUND: A novel influenza virus has emerged to produce a global pandemic four times in the past one hundred years, resulting in millions of infections, hospitalizations and deaths. There is substantial uncertainty about when, where and how the next influenza pandemic will occur. METHODS: We developed a novel mathematical model to chart the evolution of an influenza pandemic. We estimate the likely burden of future influenza pandemics through health and economic endpoints. An important component of this is the adequacy of existing hospital-resource capacity. Using a simulated population reflective of Ottawa, Canada, we model the potential impact of a future influenza pandemic under different combinations of pharmaceutical and non-pharmaceutical interventions. RESULTS: There was substantial variation in projected pandemic impact and outcomes across intervention scenarios. In a population of 1.2 million, the illness attack rate ranged from 8.4% (all interventions) to 54.5% (no interventions); peak acute care hospital capacity ranged from 0.2% (all interventions) to 13.8% (no interventions); peak ICU capacity ranged from 1.1% (all interventions) to 90.2% (no interventions); and mortality ranged from 11 (all interventions) to 363 deaths (no interventions). Associated estimates of economic burden ranged from CAD $115 million to over $2 billion when extended mass school closure was implemented. DISCUSSION: Children accounted for a disproportionate number of pandemic infections, particularly in household settings. Pharmaceutical interventions effectively reduced peak and total pandemic burden without affecting timing, while non-pharmaceutical measures delayed and attenuated pandemic wave progression. The timely implementation of a layered intervention bundle appeared likely to protect hospital resource adequacy in Ottawa. The adaptable nature of this model provides value in informing pandemic preparedness policy planning in situations of uncertainty, as scenarios can be updated in real time as more data become available. However-given the inherent uncertainties of model assumptions-results should be interpreted with caution.

Authors

  • Saunders-Hastings, Patrick, Saunders-Hastings P, University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario, Canada.; University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.

  • Quinn Hayes, Bryson, Quinn Hayes B, University of Ottawa, Department of Mathematics, Ottawa, ON, Canada.

  • Smith, Robert, Smith R, University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.; University of Ottawa, Department of Mathematics, Ottawa, ON, Canada.

  • Krewski, Daniel, Krewski D, University of Ottawa, McLaughlin Centre for Population Health Risk Assessment, 850 Peter Morand Crescent, Ottawa, Ontario, Canada.; University of Ottawa, School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, Ottawa, ON, Canada.

YEAR OF PUBLICATION: 2017
SOURCE: PLoS One. 2017 Jun 14;12(6):e0179315. doi: 10.1371/journal.pone.0179315. eCollection 2017.
JOURNAL TITLE ABBREVIATION: PLoS One
JOURNAL TITLE: PloS one
ISSN: 1932-6203 (Electronic) 1932-6203 (Linking)
VOLUME: 12
ISSUE: 6
PAGES: e0179315
PLACE OF PUBLICATION: United States
ABSTRACT:
BACKGROUND: A novel influenza virus has emerged to produce a global pandemic four times in the past one hundred years, resulting in millions of infections, hospitalizations and deaths. There is substantial uncertainty about when, where and how the next influenza pandemic will occur. METHODS: We developed a novel mathematical model to chart the evolution of an influenza pandemic. We estimate the likely burden of future influenza pandemics through health and economic endpoints. An important component of this is the adequacy of existing hospital-resource capacity. Using a simulated population reflective of Ottawa, Canada, we model the potential impact of a future influenza pandemic under different combinations of pharmaceutical and non-pharmaceutical interventions. RESULTS: There was substantial variation in projected pandemic impact and outcomes across intervention scenarios. In a population of 1.2 million, the illness attack rate ranged from 8.4% (all interventions) to 54.5% (no interventions); peak acute care hospital capacity ranged from 0.2% (all interventions) to 13.8% (no interventions); peak ICU capacity ranged from 1.1% (all interventions) to 90.2% (no interventions); and mortality ranged from 11 (all interventions) to 363 deaths (no interventions). Associated estimates of economic burden ranged from CAD $115 million to over $2 billion when extended mass school closure was implemented. DISCUSSION: Children accounted for a disproportionate number of pandemic infections, particularly in household settings. Pharmaceutical interventions effectively reduced peak and total pandemic burden without affecting timing, while non-pharmaceutical measures delayed and attenuated pandemic wave progression. The timely implementation of a layered intervention bundle appeared likely to protect hospital resource adequacy in Ottawa. The adaptable nature of this model provides value in informing pandemic preparedness policy planning in situations of uncertainty, as scenarios can be updated in real time as more data become available. However-given the inherent uncertainties of model assumptions-results should be interpreted with caution.
LANGUAGE: eng
DATE OF PUBLICATION: 2017
DATE OF ELECTRONIC PUBLICATION: 20170614
DATE COMPLETED: 20170925
DATE REVISED: 20241003
MESH DATE: 2017/09/26 06:00
EDAT: 2017/06/15 06:00
STATUS: MEDLINE
PUBLICATION STATUS: epublish
LOCATION IDENTIFIER: 10.1371/journal.pone.0179315 [doi] e0179315
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski